Seelos Therapeutics, Inc. (SEEL) Stock Analysis
DELISTED 2024
What happened to Seelos Therapeutics, Inc. (SEEL) stock?
Seelos Therapeutics, Inc. (SEEL) no longer trades on public markets. It was delisted in October 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- October 2024
- Last recorded price (historical):
- $0.37 (last quote on record before the October 2024 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Seelos Therapeutics, Inc. (SEEL). Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for central nervous system, respiratory, and other disorders.
Last analyzed: Mar 16, 2026Dated analysis: the newest financial statements on file are 31 months old (Mar 1, 2024), so the figures and score below describe that period, not today.
Seelos Therapeutics, Inc. (SEEL) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SEEL shares?
No. SEEL stopped trading on public markets in October 2024, so the shares are not available through a broker. Anything you see quoted for SEEL elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SEEL stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Seelos Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.